1. A comparison of some pharmacological actions of morphine and Δ9-tetrahydrocannabinol in the mouse;Bloom;Psychopharmacology,1978
2. Bloom, A.S. and Hillard, C.J., Cannabinoids, neurotransmitters, receptors, and brain membranes. In D.J. Harvey (Ed.), Marijuana '84, IRL Press, Oxford, 1985, pp. 217–231.
3. Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity;Bunney;J. Pharmacol. Exp. Ther.,1973
4. Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis;Chen;Psychopharmacology,1990
5. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons;French;Eur. J. Pharmacol.,1992